Αποτελέσματα Αναζήτησης
Objective. To determine the effect of serotonin transporter polymorphism promoter region (5-HTTPLR) genotypic variation (low, intermediate, and high expression groups) on response to escitalopram treatment of children and adolescents with Autism Spectrum Disorders (ASDs).
- PMC Free Article
There is no post-mortem state of symptoms that can be...
- PMC Free Article
Medications covered include serotonin reuptake inhibitors (SRIs), mirtazapine, antipsychotics, psychostimulants, atomoxetine, α-2 agonists, D-cycloserine, and memantine. Overall, SRIs are less efficacious and more poorly tolerated in children with ASDs than in adults.
7 Δεκ 2022 · Go to: Evidence about the use of pharmacologic agents in the treatment of Anorexia Nervosa (AN) is lacking, especially in childhood and adolescence. A systematic scoping review was conducted to outline current literature evidence about the use of antipsychotics in this population.
1 Σεπ 2017 · Aripiprazole was approved by the FDA in 2009 for the treatment of ASD-associated behavioral dysregulation in children and adolescents (ages 6–17). Aripiprazole is dose-independent of weight, with a recommended starting dose of 2 mg daily (see Table 1).
11 Αυγ 2024 · The growing interest in using Lexapro for autism-related symptoms stems from the observation that many individuals with ASD experience co-occurring conditions such as anxiety and depression. These comorbidities can exacerbate the core symptoms of autism and significantly impact quality of life.
10 Οκτ 2018 · In response to the elevated levels of overweight and obesity among children with autism spectrum disorder (ASD), this article provides a systematic review of the extant empirical literature...
2 Μαρ 2021 · Anorexia nervosa (AN) is an increasingly common eating disorder in which individuals limit their food intake, have a marked fear of gaining weight, and their body weight and/or shape excessively influences their self-evaluation .
